Vite, Charles H
Now showing 1 - 2 of 2
PublicationA Digital Atlas of the Dog Brain(2012-12-20) Datta, Ritobrato; Lee, Jongho; Avants, Brian B; Vite, Charles H; Gee, Jim C; Aguirre, Geoffrey K; Aguirre, Gustavo D; Duda, Jeffrey; Avants, Brian B; Vite, Charles H; Tseng, Ben; Gee, Jim C; Aguirre, Geoffrey KThere is a long history and a growing interest in the canine as a subject of study in neuroscience research and in translational neurology. In the last few years, anatomical and functional magnetic resonance imaging (MRI) studies of awake and anesthetized dogs have been reported. Such efforts can be enhanced by a population atlas of canine brain anatomy to implement group analyses. Here we present a canine brain atlas derived as the diffeomorphic average of a population of fifteen mesaticephalic dogs. The atlas includes: 1) A brain template derived from in-vivo, T1-weighted imaging at 1 mm isotropic resolution at 3 Tesla (with and without the soft tissues of the head); 2) A co-registered, high-resolution (0.33 mm isotropic) template created from imaging of ex-vivo brains at 7 Tesla; 3) A surface representation of the gray matter/white matter boundary of the high-resolution atlas (including labeling of gyral and sulcal features). The properties of the atlas are considered in relation to historical nomenclature and the evolutionary taxonomy of the Canini tribe. The atlas is available for download (https://cfn.upenn.edu/aguirre/wiki/public:data_plosone_2012_datta). PublicationBone Marrow Transplantation for Feline Mucopolysaccharidosis I(2007-07-01) Aguirre, Gustavo D; Ellinwood, Norman Matthew; Vite, Charles H; Colle, Marie-Anne; Weil, Margaret A; Casal, Margret L; Vite, Charles H; Wiemelt, Staci; Hasson, Christopher W; O'Malley, Thomas M; He, Xingxuan; Prociuk, Ulana; Evans, Sydney M; Melniczek, John R; Lannon, Anne; Knox, Van W; Haskins, Mark E; Vanier, Marie T; Schuchman, Edward H; Walkley, Steven U; Haskins, Mark ESevere mucopolysaccharidosis type I (MPS I) is a fatal neuropathic lysosomal storage disorder with significant skeletal involvement. Treatment involves bone marrow transplantation (BMT), and although effective, is suboptimal, due to treatment sequelae and residual disease. Improved approaches will need to be tested in animal models and compared to BMT. Herein we report on bone marrow transplantation to treat feline mucopolysaccharidosis I (MPS I). Five MPS I stably engrafted kittens, transplanted with unfractionated bone marrow (6.3 × 107–1.1 × 109 nucleated bone marrow cells per kilogram) were monitored for 13–37 months post-engraftment. The tissue total glycosaminoglycan (GAG) content was reduced to normal levels in liver, spleen, kidney, heart muscle, lung, and thyroid. Aorta GAG content was between normal and affected levels. Treated cats had a significant decrease in the brain GAG levels relative to untreated MPS I cats and a paradoxical decrease relative to normal cats. The α-l-iduronidase (IDUA) activity in the livers and spleens of transplanted MPS I cats approached heterozygote levels. In kidney cortex, aorta, heart muscle, and cerebrum, there were decreases in GAG without significant increases in detectable IDUA activity. Treated animals had improved mobility and decreased radiographic signs of disease. However, significant pathology remained, especially in the cervical spine. Corneal clouding appeared improved in some animals. Immunohistochemical and biochemical analysis documented decreased central nervous system ganglioside storage. This large animal MPS I study will serve as a benchmark of future therapies designed to improve on BMT.